EXOZ
eXoZymes, Inc.
NASDAQ: EXOZ · HEALTHCARE · BIOTECHNOLOGY
$9.98
-3.57% today
Updated 2026-04-30
Market cap
$87.31M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$7 – $18
Volume
0.0M
eXoZymes, Inc. (EXOZ) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 5
Last 5 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-31.8%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.4%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-7.5%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.32 | — | $11.12 | $10.99 | -1.2% |
| 2025-11-13 | $-0.27 | — | $16.50 | $15.26 | -7.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | — | $-0.32 | — | — | — |
| 2025-09-30 | — | $-0.27 | — | — | — |
| 2025-06-30 | — | $-0.28 | — | — | — |
| 2025-03-31 | — | $-0.22 | — | — | — |
| 2024-12-31 | — | $-0.24 | — | $137756.00 | — |
Frequently asked questions
Has eXoZymes, Inc. beaten earnings estimates?
eXoZymes, Inc. has beaten Wall Street EPS estimates in 0 of its last 5 quarterly reports.
How does EXOZ stock react to earnings?
EXOZ stock has moved an average of -4.4% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.